Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
The Laboratory of Genetics and Metabolism, |
RCV001009579 | SCV001169680 | pathogenic | Neurofibromatosis, type 1; Tibial pseudoarthrosis | 2018-11-10 | criteria provided, single submitter | research | |
Invitae | RCV001223770 | SCV001395932 | pathogenic | Neurofibromatosis, type 1 | 2019-07-12 | criteria provided, single submitter | clinical testing | This sequence change creates a premature translational stop signal (p.Gln682*) in the NF1 gene. It is expected to result in an absent or disrupted protein product. This variant is not present in population databases (ExAC no frequency). This variant has been observed in an individual affected with neurofibromatosis type I (PMID: 9452037). Loss-of-function variants in NF1 are known to be pathogenic (PMID: 10712197, 23913538). For these reasons, this variant has been classified as Pathogenic. |